Stocktoria
MCKESSON CORP MCK
MCKESSON CORP (MCK) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the distress zone. It pays a dividend yielding 0.43% (safety: safe). FY2026 revenue was $403.4B at a 1.2% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.36 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-08-11 | Wells Fargo | Equal-Weight (main) |
| 2026-08-06 | TD Cowen | Buy (main) |
| 2026-08-06 | UBS | Buy (main) |
| 2026-08-06 | Evercore ISI Group | Outperform (main) |
| 2026-07-24 | Citigroup | Buy (main) |
| 2026-07-21 | TD Cowen | Buy (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Forward estimates · earnings calendar →
Consensus analyst estimates and scheduled dates — forward-looking, may change.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Wholesale Trade · percentile among 112 companies
Percentile vs other Wholesale Trade companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | -0.119 |
| Retained earnings / assets | 0.271 |
| EBIT / assets | 0.075 |
| Equity / liabilities | -0.026 |
Sector peers · similar-size Wholesale Trade companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 6/9 | 0.58 | 18.8 | +12.4% |
| CAH | CARDINAL HEALTH INC | 6/9 | -0.03 | 32.5 | +14.2% |
| HLF | HERBALIFE LTD. | 5/9 | 0.63 | 5.7 | +0.9% |
| NUS | NU SKIN ENTERPRISES, INC. | 6/9 | 7.36 | 1.6 | -14.3% |
| COSM | Cosmos Health Inc. | 5/9 | -7.92 | — | +19.9% |
| ZSTK | ZeroStack Corp. | — | -13.69 | — | -0.5% |
| WGRX | Wellgistics Health, Inc. | 2/9 | — | — | +28.7% |
All Wholesale Trade companies →
About MCKESSON CORP
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
FAQ
Is MCK financially healthy?
MCKESSON CORP's Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does MCK pay a dividend, and is it safe?
Yes. MCKESSON CORP pays a dividend yielding about 0.43% with a 8.0% payout ratio, rated “safe” for safety.
How profitable is MCK?
In FY2026, MCKESSON CORP had a net margin of 1.2%.
Is MCK overvalued or undervalued?
MCKESSON CORP trades at about 22.9× trailing earnings — below its 10-year norm (10-year range 6.1×–701.5×, median 27.7×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for MCK?
The average Wall-Street price target for MCKESSON CORP is $991.40, about 12.8% above the recent price, from 15 analysts (consensus: buy).
Is MCK a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on MCKESSON CORP: a Piotroski F-score of 6/9, an Altman Z″ in the distress zone, a P/E of about 18.8×, a dividend yield of 0.43%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2026-03-31. Facts plus Stocktoria's own computed scores — not investment advice.